Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean A Fletcher

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
BMC Medicine|November 6, 2025
Rising metastatic prostate cancer rates but narrowing racial gapHanna Zurl, Zhiyu Qian, Klara K Pohl, et al.
World Journal of Urology|June 28, 2018
Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy eraSean A Fletcher, Sabrina S Harmouch, Marieke J Krimphove, et al.
The Journal of Urology|April 12, 2023
Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate CancerEzra Baraban, Eric Erak, Aisha Fatima, et al.
BJU International|May 1, 2026
Diagnostic and prognostic utility of PSMA-PET/CT in node-metastatic prostate cancerNicholas A Pickersgill, Rebecca Yu, Emily A Vertosick, et al.
JAMA Network Open|April 2, 2020
Geographic Distribution of Racial Differences in Prostate Cancer MortalitySean A Fletcher, Maya Marchese, Alexander P Cole, et al.
The Prostate|May 7, 2023
Effect of type of definitive treatment on race-based differences in prostate cancer-specific survivalNicola Frego, Muhieddine Labban, Benjamin V Stone, et al.
Urologic Oncology|February 19, 2018
The effect of treatment at minority-serving hospitals on outcomes for bladder cancerSean A Fletcher, Philipp Gild, Alexander P Cole, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast CancersAlexander P Cole, Chang Lu, Marieke J Krimphove, et al.
Cancer|January 9, 2019
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?Sebastian Berg, David D'Andrea, Malte W Vetterlein, et al.
Cancer|January 12, 2019
Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?Alexander P Cole, Sean A Fletcher, Sebastian Berg, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
BMC Medicine|November 6, 2025
Rising metastatic prostate cancer rates but narrowing racial gapHanna Zurl, Zhiyu Qian, Klara K Pohl, et al.
World Journal of Urology|June 28, 2018
Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy eraSean A Fletcher, Sabrina S Harmouch, Marieke J Krimphove, et al.
The Journal of Urology|April 12, 2023
Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate CancerEzra Baraban, Eric Erak, Aisha Fatima, et al.
BJU International|May 1, 2026
Diagnostic and prognostic utility of PSMA-PET/CT in node-metastatic prostate cancerNicholas A Pickersgill, Rebecca Yu, Emily A Vertosick, et al.
JAMA Network Open|April 2, 2020
Geographic Distribution of Racial Differences in Prostate Cancer MortalitySean A Fletcher, Maya Marchese, Alexander P Cole, et al.
The Prostate|May 7, 2023
Effect of type of definitive treatment on race-based differences in prostate cancer-specific survivalNicola Frego, Muhieddine Labban, Benjamin V Stone, et al.
Urologic Oncology|February 19, 2018
The effect of treatment at minority-serving hospitals on outcomes for bladder cancerSean A Fletcher, Philipp Gild, Alexander P Cole, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast CancersAlexander P Cole, Chang Lu, Marieke J Krimphove, et al.
Cancer|January 9, 2019
Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?Sebastian Berg, David D'Andrea, Malte W Vetterlein, et al.
Cancer|January 12, 2019
Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?Alexander P Cole, Sean A Fletcher, Sebastian Berg, et al.
Pageof 6